Pemrametostat
Investigational oral PRMT5 inhibitor in Phase 2 trials; first-in-class PRMT5 inhibitor for oncology; targets tumors with MTAP deletion.
Description
Pemrametostat is a research-grade compound offered by EuroAsia RND for laboratory research use only. Mechanism of action: PRMT5 Inhibitor. Purity: ≥98%. Certificate of Analysis (CoA) and Safety Data Sheet (SDS) are available on request. Contact us for current pricing and availability.
Additional information
| Effect | PRMT5 Inhibitor |
|---|---|
| Purity | ≥98% |
| Molecular Formula | C27H35N5O4 |
| CAS Number | N/A (investigational) |
